Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Oenocarpus bataua vegetable oil may help reduce hair loss by affecting a key gene pathway.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

COVID-19 can cause hair loss, but specialists can help treat it.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Treating stubborn hair loss involves both medical and emotional support options.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

More precise, personalized therapies are needed for autoimmune diseases.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.